Art & Science Symposium

A Tribute Symposium to Dr. Arthur W. Nienhuis


Wednesday, June 22, 2016
8:30 a.m. – 2:00 p.m.
Marlo Thomas Center for Global Education and Collaboration
St. Jude Children’s Research Hospital
262 Danny Thomas Place
Memphis, TN 38105
Driving directions


Art & Science Symposium

For 11 years, Dr. Nienhuis was the hospital director and CEO of St. Jude Children’s Research Hospital from the fall of 1993 until 2004. In 1998, under his leadership, St. Jude purchased the property of St. Joseph’s Hospital, which intersected our campus. This addition of more than 25 acres to our campus provided an open venue for ongoing expansion, and substantial resources were committed by the Board of Governors to undertake this expansion. During this time, the hospital completed a $1 billion expansion, with construction being initiated for the Integrated Research Center (IRC), an 11-story structure that includes six floors for direct research and several laboratory floors, and construction being completed for the Children’s Good Manufacturing Practices (GMP) facility, LLC. The GMP is one of the largest manufacturing facilities in the academic community, and today, many biological products are produced here that support the novel and innovative clinical trials of St. Jude. Dr. Nienhuis also participated in the early planning for the Chili’s Care Center, with patient clinics, inpatient rooms, and laboratory space, although construction occurred during the tenure of his successor, Dr. William Evans.

Prior to coming to St. Jude, Dr. Nienhuis was a Clinical Associate at the National Health Institute (NHI) which became the National Heart, Lung, and Blood Institute (NHLBI). While there, he started an independent research lab and founded the Clinical Hematology Service. He spent over 20 years of his career at the National Institutes of Health (NIH), developing what ultimately became the largest of the institute’s clinical programs. He has trained 65+ postdoctoral fellows who have, for the most part, prominent positions all over the world. All of the speakers for the Symposium are world renowned and were either his trainees or close colleagues and friends. Attending the conference are doctors from Sweden, Japan, and Canada who wanted to honor Dr. Nienhuis on his retirement. 

Dr. James Downing (current CEO and president of St. Jude), Dr. Mitchell Weiss (current Chair, Hematology), and Dr. Brian Sorrentino (current Division Director, Experimental Hematology) wanted to honor Dr. Nienhuis with a symposium. Dr. Weiss said this would have to be about “Art Nienhuis and Science,” just as his work was about, Art — and Science. The two fields were coming together — two majors — the Arts and the Sciences. Art and science became the theme, inspiring a Warholesque print as the centerpiece. Thus, the Art & Science Symposium was born.


Time Event
8:30–9:00 a.m. Meet & Greet with coffee, drinks and refreshments
9:00–9:10 a.m. Opening remarks: James R. Downing, MD
President and CEO, Donald Pinkel Chair of Childhood Cancer Treatment
Session One Moderator: Mitchell J. Weiss, MD, PhD
Chair, Department of Hematology, Arthur Nienhuis Endowed Chair in Hematology
9:10–9:20 a.m.


Letter from David G. Nathan, MD
President Emeritus, Dana-Farber Cancer Institute, Boston, MA [not attending]

9:20–9:40 a.m. George Stamatoyannopoulos, MD, DSci
Director, Markey Molecular Medicine Center, University of Washington, Seattle
9:40–10:00 a.m. George J. Dover, MD
Given Foundation Professor of Pediatrics, Pediatrician-in-Chief of the John Hopkins Children’s Center, Director, Department of Pediatrics, Baltimore, MD
10:00–10:20 a.m. Thalia Papayannopolis, MD
Professor of Medicine, Division of Hematology, University of Washington School of Medicine, Seattle
10:20–10:40 a.m. Keith Humphries, MD, PhD
Director, Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada
10:40–11:00 a.m. Timothy J. Ley, MD
Professor of Medicine and Genetics, Division of Oncology, Washington University School of Medicine, St. Louis, MO
11:00–11:20 a.m. Break
Session Two

Moderator: Stefan Karlsson, MD, PhD
Lund University and Lund University Hospital, Lund, Sweden

11:20–11:40 a.m. David M. Bodine, PhD
Chief  & Senior Investigator, Genetics and Molecular Biology Branch, Head, Hematopoiesis Section, NIH, Bethesda, MD
11:40 a.m.–12:00 p.m. Cynthia Dunbar, MD
Head, Molecular Hematopoiesis Section, Program Director, Hematology, NHLBI, Bethesda, MD
12:00–12:20 p.m. Brian P. Sorrentino, MD
Member and Division Chief, Experimental Hematology, St. Jude Children’s Research Hospital
12:20–12:40 p.m. Andrew Davidoff, MD
Member and Chair, Surgery Department, St. Jude Children’s Research Hospital
12:40–1:00 p.m.

Charles Sherr, MD, PhD
Member and Chair, Tumor Cell Biology Department, Investigator, Howard Hughes Medical Institute, St. Jude Children’s Research Hospital

Martine Roussel, PhD
Member, Tumor Cell Biology, St. Jude Children’s Research Hospital

1:00 p.m. Lunch (provided)

Register for the Symposium